title: Mycobacterial infections in solid organ transplant recipients.
authors.affiliation: Baskent University Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Ankara, Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Arslan
authors.forename: F
authors.initials: F
authors.lastname: Oner-Eyüboglu
authors.forename: F
authors.initials: F
authors.lastname: Kalpaklioglu
authors.forename: K
authors.initials: K
authors.lastname: Gürdogan
authors.forename: S
authors.initials: S
authors.lastname: Akçay
authors.forename: A
authors.initials: A
authors.lastname: Demirag
authors.forename: M
authors.initials: M
authors.lastname: Haberal
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009164:Mycobacterium Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000382:microbiology*; D011718:Pyrazinamide / Q000627:therapeutic use; D012189:Retrospective Studies; D012293:Rifampin / Q000627:therapeutic use; D012424:Rural Population; D012959:Socioeconomic Factors; D013997:Time Factors; D014421:Turkey
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin